{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:10:55Z","timestamp":1793945455226,"version":"4.8.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["AA021818"],"award-info":[{"award-number":["AA021818"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH091537"],"award-info":[{"award-number":["MH091537"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["AA021818"],"award-info":[{"award-number":["AA021818"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["AA021818"],"award-info":[{"award-number":["AA021818"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["P50AA12870"],"award-info":[{"award-number":["P50AA12870"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41386-018-0199-1","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T11:22:59Z","timestamp":1536232979000},"page":"2539-2547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age"],"prefix":"10.1038","volume":"43","author":[{"given":"Aishwarya","family":"Vijay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchitra","family":"Krishnan-Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan D.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"key":"199_CR1","unstructured":"SAMHSA. National Survey on Drug Use and Health (NSDUH); 2015. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-FFR1-2015\/NSDUH-FFR1-2015\/NSDUH-FFR1-2015.pdf ."},{"key":"199_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/acer.12669","volume":"39","author":"RZ Litten","year":"2015","unstructured":"Litten RZ, Ryan ML, Falk DE, Reilly M, Fertig JB, Koob GF. Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment. Alcohol Clin Exp Res. 2015;39:579\u201384.","journal-title":"Alcohol Clin Exp Res"},{"issue":"s17","key":"199_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.15288\/jsads.2014.s17.79","volume":"75","author":"LR Zindel","year":"2014","unstructured":"Zindel LR, Kranzler HR. Pharmacotherapy of alcohol use disorders: seventy-five years of progress. J Stud Alcohol Drugs Suppl. 2014;75(s17):79\u201388.","journal-title":"J Stud Alcohol Drugs Suppl"},{"key":"199_CR4","first-page":"33","volume":"31","author":"C Gianoulakis","year":"1996","unstructured":"Gianoulakis C. Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies. Med Counc Alcohol. 1996;31:33\u201342.","journal-title":"Med Counc Alcohol"},{"key":"199_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/1568026043451573","volume":"4","author":"C Gianoulakis","year":"2004","unstructured":"Gianoulakis C. Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem. 2004;4:39\u201350.","journal-title":"Curr Top Med Chem"},{"key":"199_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s002130050169","volume":"129","author":"A Herz","year":"1997","unstructured":"Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology. 1997;129:99\u2013111.","journal-title":"Psychopharmacology"},{"key":"199_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev.ne.07.030184.001255","volume":"7","author":"H Akil","year":"1984","unstructured":"Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM. Endogenous opioids: biology and function. Annu Rev Neurosci. 1984;7:223\u201355.","journal-title":"Annu Rev Neurosci"},{"key":"199_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cobeha.2016.12.002","volume":"13","author":"B Reed","year":"2017","unstructured":"Reed B, Butelman ER, Kreek MJ. Endogenous opioid system in addiction and addiction-related behaviors. Curr Opin Behav Sci. 2017;13:196\u2013202.","journal-title":"Curr Opin Behav Sci"},{"key":"199_CR9","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/brain\/awm255","volume":"131","author":"G Henriksen","year":"2007","unstructured":"Henriksen G, Willoch F. Imaging of opioid receptors in the central nervous system. Brain. 2007;131:1171\u201396.","journal-title":"Brain"},{"key":"199_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/JCP.0b013e3181ac5213","volume":"29","author":"HR Kranzler","year":"2009","unstructured":"Kranzler HR, Tennen H, Armeli S, Chan G, Covault J, Arias A, et al. Targeted naltrexone for problem drinkers. J Clin Psychopharmacol. 2009;29:350.","journal-title":"J Clin Psychopharmacol"},{"key":"199_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jsat.2007.05.011","volume":"34","author":"HM Pettinati","year":"2008","unstructured":"Pettinati HM, Kampman KM, Lynch KG, Suh JJ, Dackis CA, Oslin DW, et al. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abus Treat. 2008;34:378\u201390.","journal-title":"J Subst Abus Treat"},{"key":"199_CR12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1530-0277.2007.00347.x","volume":"31","author":"SS O\u2019Malley","year":"2007","unstructured":"O\u2019Malley SS, Sinha R, Grilo CM, Capone C, Farren CK, McKee SA, et al. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol\u2010dependent women: a randomized controlled trial. Alcohol Clin Exp Res. 2007;31:625\u201334.","journal-title":"Alcohol Clin Exp Res"},{"key":"199_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1530-0277.2008.00633.x","volume":"32","author":"A Baros","year":"2008","unstructured":"Baros A, Latham P, Anton R. Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist? Alcohol Clin Exp Res. 2008;32:771\u20136.","journal-title":"Alcohol Clin Exp Res"},{"key":"199_CR14","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1111\/j.1530-0277.2010.01267.x","volume":"34","author":"SF Greenfield","year":"2010","unstructured":"Greenfield SF, Pettinati HM, O\u2019Malley S, Randall PK, Randall CL. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study. Alcohol Clin Exp Res. 2010;34:1803\u201312.","journal-title":"Alcohol Clin Exp Res"},{"key":"199_CR15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.biopsych.2006.11.018","volume":"62","author":"S Krishnan-Sarin","year":"2007","unstructured":"Krishnan-Sarin S, Krystal JH, Shi J, Pittman B, O\u2019Malley SS. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol Psychiatry. 2007;62:694\u20137.","journal-title":"Biol Psychiatry"},{"key":"199_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s002130050156","volume":"129","author":"AC King","year":"1997","unstructured":"King AC, Volpicelli JR, Frazer A, O\u2019Brien CP. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology. 1997;129:15\u201322.","journal-title":"Psychopharmacology"},{"key":"199_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/105504901750532148","volume":"10","author":"JR Monterosso","year":"2001","unstructured":"Monterosso JR, Flannery BA, Pettinati HM, Oslin DW, Rukstalis M, O\u2019Brien CP, et al. Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict. 2001;10:258\u201368.","journal-title":"Am J Addict"},{"key":"199_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.lfs.2010.10.007","volume":"88","author":"K Rasakham","year":"2011","unstructured":"Rasakham K, Liu-Chen L-Y. Sex differences in kappa opioid pharmacology. Life Sci. 2011;88:2\u201316.","journal-title":"Life Sci"},{"key":"199_CR19","first-page":"205","volume":"6","author":"A Vijay","year":"2016","unstructured":"Vijay A, Wang S, Worhunsky P, Zheng M-Q, Nabulsi N, Ropchan J, et al. PET imaging reveals sex differences in kappa opioid receptor availability in humans, in vivo. Am J Nucl Med Mol Imaging. 2016;6:205\u201314.","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"199_CR20","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1176\/ajp.156.6.842","volume":"156","author":"JK Zubieta","year":"1999","unstructured":"Zubieta J-K, Dannals RF, Frost JJ. Gender and age influences on human brain Mu-opioid receptor binding measured by PET. Am J Psychiatry. 1999;156:842\u20138.","journal-title":"Am J Psychiatry"},{"key":"199_CR21","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fnins.2015.00466","volume":"9","author":"EH Chartoff","year":"2015","unstructured":"Chartoff EH, Mavrikaki M. Sex differences in kappa opioid receptor function and their potential impact on addiction. Front Neurosci. 2015;9:466.","journal-title":"Front Neurosci"},{"key":"199_CR22","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","volume":"293","author":"JC Garbutt","year":"2005","unstructured":"Garbutt JC, Kranzler HR, O\u2019Malley SS, Gastfriend DR, Pettinati HM, Silverman BL, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005;293:1617\u201325.","journal-title":"JAMA"},{"key":"199_CR23","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1530-0277.2006.00101.x","volume":"30","author":"CA Hernandez\u2010Avila","year":"2006","unstructured":"Hernandez\u2010Avila CA, Song C, Kuo L, Tennen H, Armeli S, Kranzler HR. Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking. Alcohol Clin Exp Res. 2006;30:860\u20135.","journal-title":"Alcohol Clin Exp Res"},{"key":"199_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/1874473710801020239","volume":"1","author":"M M\u00e9ndez","year":"2008","unstructured":"M\u00e9ndez M, Morales-Mulia M. Role of mu and delta opioid receptors in alcohol drinking behaviour. Curr Drug Abus Rev. 2008;1:239\u201352.","journal-title":"Curr Drug Abus Rev"},{"key":"199_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0165-6147(98)01169-9","volume":"19","author":"ZZ Pan","year":"1998","unstructured":"Pan ZZ. mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci. 1998;19:94\u20138.","journal-title":"Trends Pharmacol Sci"},{"key":"199_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.alcohol.2011.10.006","volume":"46","author":"BM Walker","year":"2012","unstructured":"Walker BM, Valdez GR, McLaughlin JP, Bakalkin G. Targeting dynorphin\/kappa opioid receptor systems to treat alcohol abuse and dependence. Alcohol. 2012;46:359\u201370.","journal-title":"Alcohol"},{"key":"199_CR27","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0091-3057(93)90527-Z","volume":"45","author":"P Hyyti\u00e4","year":"1993","unstructured":"Hyyti\u00e4 P. Involvement of \u03bc-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav. 1993;45:697\u2013701.","journal-title":"Pharmacol Biochem Behav"},{"key":"199_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archpsyc.62.1.57","volume":"62","author":"A Heinz","year":"2005","unstructured":"Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G, et al. Correlation of stable elevations in striatal \u03bc-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11\u2013labeled carfentanil. Arch Gen Psychiatry. 2005;62:57\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"199_CR29","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1111\/j.1530-0277.2011.01565.x","volume":"35","author":"EM Weerts","year":"2011","unstructured":"Weerts EM, Wand GS, Kuwabara H, Munro CA, Dannals RF, Hilton J, et al. Positron emission tomography imaging of mu\u2010and delta\u2010opioid receptor binding in alcohol\u2010dependent and healthy control subjects. Alcohol Clin Exp Res. 2011;35:2162\u201373.","journal-title":"Alcohol Clin Exp Res"},{"key":"199_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopsych.2003.07.007","volume":"55","author":"B Bencherif","year":"2004","unstructured":"Bencherif B, Wand GS, McCaul ME, Kim YK, Ilgin N, Dannals RF, et al. Mu-opioid receptor binding measured by [11 C] carfentanil positron emission tomography is related to craving and mood in alcohol dependence. Biol Psychiatry. 2004;55:255\u201362.","journal-title":"Biol Psychiatry"},{"key":"199_CR31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","volume":"116","author":"T Shippenberg","year":"2007","unstructured":"Shippenberg T, Zapata A, Chefer V. Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther. 2007;116:306\u201321.","journal-title":"Pharmacol Ther"},{"key":"199_CR32","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/01.ALC.0000164361.62346.D6","volume":"29","author":"KM Kovacs","year":"2005","unstructured":"Kovacs KM, Szakall I, O\u2019brien D, Wang R, Vinod KY, Saito M, et al. Decreased oral self\u2010administration of alcohol in \u03ba\u2010opioid receptor knock\u2010out mice. Alcohol Clin Exp Res. 2005;29:730\u20138.","journal-title":"Alcohol Clin Exp Res"},{"key":"199_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0741-8329(00)00118-X","volume":"22","author":"S Lindholm","year":"2000","unstructured":"Lindholm S, Ploj K, Franck J, Nylander I. Repeated ethanol administration induces short-and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. Alcohol. 2000;22:165\u201371.","journal-title":"Alcohol"},{"key":"199_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(99)00675-8","volume":"275","author":"Aring Rosin","year":"1999","unstructured":"Rosin \u00c5, Lindholm S, Franck J, Georgieva J. Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens. Neurosci Lett. 1999;275:1\u20134.","journal-title":"Neurosci Lett"},{"key":"199_CR35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1124\/jpet.115.229278","volume":"356","author":"M Naganawa","year":"2016","unstructured":"Naganawa M, Dickinson GL, Zheng M-Q, Henry S, Vandenhende F, Witcher J, et al. Receptor occupancy of the \u03ba-opioid antagonist LY2456302 measured with positron emission tomography and the novel radiotracer 11C-LY2795050. J Pharmacol Exp Ther. 2016;356:260\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"199_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2967\/jnumed.114.147975","volume":"56","author":"M Naganawa","year":"2015","unstructured":"Naganawa M, Zheng M-Q, Henry S, Nabulsi N, Lin S-F, Ropchan J, et al. Test\u2013retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the \u03ba opioid receptor. J Nucl Med. 2015;56:243\u20138.","journal-title":"J Nucl Med"},{"key":"199_CR37","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/jcbfm.2014.150","volume":"34","author":"M Naganawa","year":"2014","unstructured":"Naganawa M, Zheng M-Q, Nabulsi N, Tomasi G, Henry S, Lin S-F, et al. Kinetic modeling of 11C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans. J Cereb Blood Flow Metab. 2014;34:1818\u201325.","journal-title":"J Cereb Blood Flow Metab"},{"key":"199_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainresrev.2009.09.008","volume":"62","author":"AW Bruijnzeel","year":"2009","unstructured":"Bruijnzeel AW. kappa-Opioid receptor signaling and brain reward function. Brain Res Rev. 2009;62:127\u201346.","journal-title":"Brain Res Rev"},{"key":"199_CR39","doi-asserted-by":"publisher","first-page":"8000","DOI":"10.1021\/jm200789r","volume":"54","author":"CH Mitch","year":"2011","unstructured":"Mitch CH, Quimby SJ, Diaz N, Pedregal C, de la Torre MG, Jimenez A, et al. Discovery of aminobenzyloxyarylamides as \u03ba opioid receptor selective antagonists: application to preclinical development of a \u03ba opioid receptor antagonist receptor occupancy tracer. J Med Chem. 2011;54:8000\u201312.","journal-title":"J Med Chem"},{"key":"199_CR40","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.2967\/jnumed.112.118877","volume":"54","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Zheng M-Q, Nabulsi N, Labaree D, Ropchan J, Najafzadeh S, et al. Determination of the in vivo selectivity of a new \u03ba-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey. J Nucl Med. 2013;54:1668\u201374.","journal-title":"J Nucl Med"},{"key":"199_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2967\/jnumed.112.109512","volume":"54","author":"MQ Zheng","year":"2013","unstructured":"Zheng M-Q, Nabulsi N, Kim SJ, Tomasi G, Lin S-f, Mitch C, et al. Synthesis and evaluation of 11C-LY2795050 as a \u03ba-opioid receptor antagonist radiotracer for PET imaging. J Nucl Med. 2013;54:455\u201363.","journal-title":"J Nucl Med"},{"key":"199_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring Alcohol Consumption","author":"Linda C. Sobell","year":"1992","unstructured":"Sobell LC, Sobell MB. Timeline follow-back. In: Measuring alcohol consumption. Berlin: Springer; 1992. pp 41\u201372."},{"key":"199_CR43","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","volume":"84","author":"JT Sullivan","year":"1989","unstructured":"Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA\u2010Ar). Br J Addict. 1989;84:1353\u20137.","journal-title":"Br J Addict"},{"key":"199_CR44","unstructured":"Carson RE, Barker WC, Liow J-S, Johnson C, editors. Design of a motion-compensation OSEM list-mode algorithm for resolution-recovery reconstruction for the HRRT. 2003 IEEE Nuclear Science Symposium Conference Record, 2003 IEEE. Portland, OR: IEEE; 2003."},{"key":"199_CR45","doi-asserted-by":"publisher","first-page":"102503","DOI":"10.1118\/1.4819820","volume":"40","author":"X Jin","year":"2013","unstructured":"Jin X, Mulnix T, Gallezot J-D, Carson RE. Evaluation of motion correction methods in human brain PET imaging\u2014A simulation study based on human motion data. Med Phys. 2013;40:102503.","journal-title":"Med Phys"},{"key":"199_CR46","first-page":"1471","volume":"45","author":"G Giovacchini","year":"2004","unstructured":"Giovacchini G, Lerner A, Toczek MT, Fraser C, Ma K, DeMar JC, et al. Brain incorporation of 11C-arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction. J Nucl Med. 2004;45:1471\u20139.","journal-title":"J Nucl Med"},{"key":"199_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273\u201389.","journal-title":"Neuroimage"},{"key":"199_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang D-R, Huang Y, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab. 2003;23:285\u2013300.","journal-title":"J Cereb Blood Flow Metab"},{"key":"199_CR49","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1523\/JNEUROSCI.1554-07.2007","volume":"27","author":"BW Balleine","year":"2007","unstructured":"Balleine BW, Delgado MR, Hikosaka O. The role of the dorsal striatum in reward and decision-making. J Neurosci. 2007;27:8161\u20135.","journal-title":"J Neurosci"},{"key":"199_CR50","first-page":"125","volume":"27","author":"M Oscar-Berman","year":"2003","unstructured":"Oscar-Berman M, Marinkovic K. Alcoholism and the brain: an overview. Alcohol Res Health. 2003;27:125\u201333.","journal-title":"Alcohol Res Health"},{"key":"199_CR51","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/syn.10226","volume":"49","author":"I Boileau","year":"2003","unstructured":"Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M, et al. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse. 2003;49:226\u201331.","journal-title":"Synapse"},{"key":"199_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1361-8415(01)80004-9","volume":"1","author":"WM Wells","year":"1996","unstructured":"Wells WM, Viola P, Atsumi H, Nakajima S, Kikinis R. Multi-modal volume registration by maximization of mutual information. Med Image Anal. 1996;1:35\u201351.","journal-title":"Med Image Anal"},{"key":"199_CR53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/jcbfm.2009.195","volume":"30","author":"JD Gallezot","year":"2010","unstructured":"Gallezot J-D, Nabulsi N, Neumeister A, Planeta-Wilson B, Williams WA, Singhal T, et al. Kinetic modeling of the serotonin 5-HT1B receptor radioligand [11C] P943 in humans. J Cereb Blood Flow Metab. 2010;30:196\u2013210.","journal-title":"J Cereb Blood Flow Metab"},{"key":"199_CR54","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radio ligands. J Cereb Blood Flow Metab. 2007;27:1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"199_CR55","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/sim.4780090710","volume":"9","author":"Y Hochberg","year":"1990","unstructured":"Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9:811\u20138.","journal-title":"Stat Med"},{"key":"199_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.drugalcdep.2016.12.019","volume":"173","author":"KE Lind","year":"2017","unstructured":"Lind KE, Gutierrez EJ, Yamamoto DJ, Regner MF, McKee SA, Tanabe J. Sex disparities in substance abuse research: Evaluating 23 years of structural neuroimaging studies. Drug Alcohol Depend. 2017;173:92\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"199_CR57","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1176\/appi.ajp.2008.07121877","volume":"165","author":"J Wrase","year":"2008","unstructured":"Wrase J, Makris N, Braus DF, Mann K, Smolka MN, Kennedy DN, et al. Amygdala volume associated with alcohol abuse relapse and craving. Am J Psychiatry. 2008;165:1179\u201384.","journal-title":"Am J Psychiatry"},{"key":"199_CR58","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00429-010-0259-8","volume":"214","author":"H Garavan","year":"2010","unstructured":"Garavan H. Insula and drug cravings. Brain Struct Funct. 2010;214:593\u2013601.","journal-title":"Brain Struct Funct"},{"key":"199_CR59","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.biopsych.2005.04.044","volume":"58","author":"D Martinez","year":"2005","unstructured":"Martinez D, Gil R, Slifstein M, Hwang D-R, Huang Y, Perez A, et al. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry. 2005;58:779\u201386.","journal-title":"Biol Psychiatry"},{"key":"199_CR60","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/archpsyc.65.4.466","volume":"65","author":"H Myrick","year":"2008","unstructured":"Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K. Effect of naltrexone and ondansetron on alcohol cue\u2013induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry. 2008;65:466\u201375.","journal-title":"Arch Gen Psychiatry"},{"key":"199_CR61","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s007020170038","volume":"108","author":"D Braus","year":"2001","unstructured":"Braus D, Wrase J, Gr\u00fcsser S, Hermann D, Ruf M, Flor He, et al. Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholics. J Neural Transm. 2001;108:887\u201394.","journal-title":"J Neural Transm"},{"key":"199_CR62","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/0024-3205(83)90401-0","volume":"32","author":"BA Gosnell","year":"1983","unstructured":"Gosnell BA, Levine AS, Morley JE. The effects of aging on opioid modulation of feeding in rats. Life Sci. 1983;32:2793\u20139.","journal-title":"Life Sci"},{"issue":"suppl_2","key":"199_CR63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/gerona\/56.suppl_2.81","volume":"56","author":"JE Morley","year":"2001","unstructured":"Morley JE. Decreased food intake with aging. J Gerontol A. 2001;56(suppl_2):81\u20138.","journal-title":"J Gerontol A"},{"key":"199_CR64","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neurobiolaging.2017.05.006","volume":"57","author":"TM Karrer","year":"2017","unstructured":"Karrer TM, Josef AK, Mata R, Morris ED, Samanez-Larkin GR. Reduced dopamine receptors and transporters but not synthesis capacity in normal aging adults: a meta-analysis. Neurobiol Aging. 2017;57:36\u201346.","journal-title":"Neurobiol Aging"},{"key":"199_CR65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1176\/ajp.157.1.75","volume":"157","author":"ND Volkow","year":"2000","unstructured":"Volkow ND, Logan J, Fowler JS, Wang G-J, Gur RC, Wong C, et al. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry. 2000;157:75\u201380.","journal-title":"Am J Psychiatry"},{"key":"199_CR66","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/sj.npp.1301412","volume":"33","author":"GJ Dowling","year":"2008","unstructured":"Dowling GJ, Weiss SR, Condon TP. Drugs of abuse and the aging brain. Neuropsychopharmacology. 2008;33:209\u201318.","journal-title":"Neuropsychopharmacology"},{"key":"199_CR67","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0006-8993(90)90423-9","volume":"508","author":"JO Rinne","year":"1990","unstructured":"Rinne JO, L\u00f6nnberg P, Marjam\u00e4ki P. Age-dependent decline in human brain dopamine D 1 and D 2 receptors. Brain Res. 1990;508:349\u201352.","journal-title":"Brain Res"},{"key":"199_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<56::AID-SYN7>3.0.CO;2-J","volume":"30","author":"Y Wang","year":"1998","unstructured":"Wang Y, Chan GL, Holden JE, Dobko T, Mak E, Schulzer M, et al. Age\u2010dependent decline of dopamine D1 receptors in human brain: A PET study. Synapse. 1998;30:56\u201361.","journal-title":"Synapse"},{"key":"199_CR69","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1176\/appi.ajp.2009.08121801","volume":"166","author":"D Martinez","year":"2009","unstructured":"Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R, et al. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D 2\/D 3 receptors following acute dopamine depletion. Am J Psychiatry. 2009;166:1170\u20137.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"199_CR70","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TODD F. HEATHERTON","year":"1991","unstructured":"Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. O. (1991). The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Addiction, 86(9), 1119\u20131127.","journal-title":"Addiction"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0199-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0199-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T22:34:50Z","timestamp":1693866890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-018-0199-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":70,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1038\/s41386-018-0199-1","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,6]]},"assertion":[{"value":"29 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}